Under the Z-Gu intervention, the quantity and quality of gallstones were higher, and the incidence of gallstones was higher than in the Gly-MCA intervention (Fig. 6A and B), suggesting that it was the global FXR that reduced CGS formation, not the intestinal FXR alone. The gene discussed is NR1H4; the disease is gallstones.